Ordonez Claudia 4
4 · Keros Therapeutics, Inc. · Filed May 13, 2021
Insider Transaction Report
Form 4
Ordonez Claudia
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-11$0.48/sh+1,000$480→ 1,000 total - Sale
Common Stock
2021-05-11$50.15/sh−1,000$50,150→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-05-11−1,000→ 99,211 totalExercise: $0.48Exp: 2029-09-18→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]One-quarter (1/4th) of the shares subject to the option shall vest on September 16, 2020, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.